PRMT6 Inhibitor Discovery (with Agora, Variational AI)

About Enamine

Enamine operates as a hybrid chemical supplier and drug discovery CRO, uniquely positioned at the intersection of physical chemistry and computational design. It maintains the world's largest in-stock collection of building blocks (over 300,000 compounds) and offers access to trillions of make-on-demand compounds through its Enamine REAL virtual space. The company is increasingly focused on integrating advanced AI/ML modeling and participating in high-profile open-science collaborations to drive next-generation drug discovery, particularly in challenging target areas. Its business model is built on a combination of product sales, custom synthesis services, and collaborative R&D partnerships.

Other Spinal and Bulbar Muscular Atrophy (SBMA) Drugs